Roger Esteban-Fabró

803 total citations
8 papers, 152 citations indexed

About

Roger Esteban-Fabró is a scholar working on Oncology, Hepatology and Cancer Research. According to data from OpenAlex, Roger Esteban-Fabró has authored 8 papers receiving a total of 152 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Hepatology and 4 papers in Cancer Research. Recurrent topics in Roger Esteban-Fabró's work include Cancer Genomics and Diagnostics (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Roger Esteban-Fabró is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Roger Esteban-Fabró collaborates with scholars based in Spain, United States and Italy. Roger Esteban-Fabró's co-authors include Josep M. Llovet, Laia Bassaganyas, Roser Pinyol, Daniela Sia, Jordi Camps, María Vila-Casadesús, Robert Montal, Sebastià Franch‐Expósito, Vincenzo Mazzaferro and Judit Peix and has published in prestigious journals such as Bioinformatics, Cancer Research and Clinical Cancer Research.

In The Last Decade

Roger Esteban-Fabró

8 papers receiving 151 citations

Peers

Roger Esteban-Fabró

CR

HEPAT

ONCOL

PRM

MB

Sarah Cappuyns Belgium

Elena Rota Caremoli Italy

Takashi Mineo Japan

Yichuan Yuan China

Mengxian Tu China

Takayoshi Kaida Japan

Youpei Lin China

Kazuki Maesaka Japan

Shujie Pang China

Patricia Rich United States

Sarah Cappuyns Belgium

Roger Esteban-Fabró

53 ×0.7

CR

80 ×1.1

HEPAT

78 ×1.3

ONCOL

40 ×0.9

PRM

75 ×1.9

MB

Citations per year, relative to Roger Esteban-Fabró Roger Esteban-Fabró (= 1×) peers Sarah Cappuyns

Countries citing papers authored by Roger Esteban-Fabró

Since Specialization

Citations

This map shows the geographic impact of Roger Esteban-Fabró's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Esteban-Fabró with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Esteban-Fabró more than expected).

Fields of papers citing papers by Roger Esteban-Fabró

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Esteban-Fabró. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Esteban-Fabró. The network helps show where Roger Esteban-Fabró may publish in the future.

Co-authorship network of co-authors of Roger Esteban-Fabró

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Esteban-Fabró. A scholar is included among the top collaborators of Roger Esteban-Fabró based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Esteban-Fabró. Roger Esteban-Fabró is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Esteban-Fabró, Roger, Ermengol Coma, Eduardo Hermosilla, et al.. (2024). Information provision and financial incentives in Catalonia's public primary care (2010–2019): an interrupted time series analysis. The Lancet Regional Health - Europe. 47. 101102–101102. 1 indexed citations

2.

Franch‐Expósito, Sebastià, et al.. (2022). PCIG: a web-based application to explore immune–genomics interactions across cancer types. Bioinformatics. 38(8). 2374–2376. 1 indexed citations

3.

Bassaganyas, Laia, Roser Pinyol, Roger Esteban-Fabró, et al.. (2020). Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma. Clinical Cancer Research. 26(23). 6350–6361. 40 indexed citations

4.

Franch‐Expósito, Sebastià, Laia Bassaganyas, María Vila-Casadesús, et al.. (2020). CNApp, a tool for the quantification of copy number alterations and integrative analysis revealing clinical implications. eLife. 9. 39 indexed citations

5.

Esteban-Fabró, Roger, Catherine E. Willoughby, Marta Piqué‐Gili, et al.. (2020). Cabozantinib enhances the efficacy and immune modulatory activity of anti-PD1 therapy in a syngeneic mouse model of hepatocellular carcinoma. Journal of Hepatology. 73. S40–S40. 6 indexed citations

6.

Montal, Robert, Carmen Andreu-Oller, Laia Bassaganyas, et al.. (2019). Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials. British Journal of Cancer. 121(4). 340–343. 63 indexed citations

7.

Esteban-Fabró, Roger, Laia Bassaganyas, Sara Torrecilla, et al.. (2019). Abstract 3095: Aneuploidy profiles in hepatocellular carcinoma and their impact on tumor progression and immune features. Cancer Research. 79(13_Supplement). 3095–3095. 1 indexed citations

8.

Esteban-Fabró, Roger, Laia Bassaganyas, Sara Torrecilla, et al.. (2019). Abstract 3095: Aneuploidy profiles in hepatocellular carcinoma and their impact on tumor progression and immune features. 3095–3095. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact